- Home
- LZM vs FDMT Comparison
LZM vs FDMT Comparison
Compare LZM & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LZM
- FDMT
- Stock Information
- Founded
- LZM 2021
- FDMT 2013
- Country
- LZM Isle of Man
- FDMT United States
- Employees
- LZM N/A
- FDMT N/A
- Industry
- LZM Metal Mining
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- LZM Basic Materials
- FDMT Health Care
- Exchange
- LZM Nasdaq
- FDMT Nasdaq
- Market Cap
- LZM 333.0M
- FDMT 391.8M
- IPO Year
- LZM N/A
- FDMT 2020
- Fundamental
- Price
- LZM $3.86
- FDMT $10.38
- Analyst Decision
- LZM Strong Buy
- FDMT Strong Buy
- Analyst Count
- LZM 2
- FDMT 9
- Target Price
- LZM $10.50
- FDMT $30.33
- AVG Volume (30 Days)
- LZM 192.6K
- FDMT 1.1M
- Earning Date
- LZM 08-11-2025
- FDMT 11-10-2025
- Dividend Yield
- LZM N/A
- FDMT N/A
- EPS Growth
- LZM N/A
- FDMT N/A
- EPS
- LZM N/A
- FDMT N/A
- Revenue
- LZM $416,323.00
- FDMT $120,000.00
- Revenue This Year
- LZM $611.56
- FDMT $8,572.97
- Revenue Next Year
- LZM $344.44
- FDMT $6.05
- P/E Ratio
- LZM N/A
- FDMT N/A
- Revenue Growth
- LZM N/A
- FDMT 605.88
- 52 Week Low
- LZM $2.90
- FDMT $2.24
- 52 Week High
- LZM $7.29
- FDMT $12.34
- Technical
- Relative Strength Index (RSI)
- LZM 30.72
- FDMT 49.14
- Support Level
- LZM $3.77
- FDMT $10.00
- Resistance Level
- LZM $4.00
- FDMT $11.43
- Average True Range (ATR)
- LZM 0.31
- FDMT 0.87
- MACD
- LZM -0.05
- FDMT -0.17
- Stochastic Oscillator
- LZM 17.43
- FDMT 22.97
About LZM Lifezone Metals Limited
Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises three segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary and corporate.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.